Payment overview · 2025
General Payments
$35.87
2 reported records · 2 companies
Healthcare provider profile · identity verified
Jason S So, DO
Allopathic & Osteopathic Physicians|Family Medicine · LAKE GENEVA, WI · NPI 1508078643
Verified facts
What the public records show
CMS Open Payments records show Jason S So, DO received $35.87 in general payments during 2025 across 2 reported records.
Alkermes, Inc. accounted for 55.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Alkermes, Inc. | Unresolved — no canonical attribution shown | $19.89 | 55.5% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $15.98 | 44.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.87 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VIVITROL Normalized: vivitrol |
Drug | Alkermes, Inc. | $19.89 | 1 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $15.98 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $15.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 724 | 195 |
| Lisinopril | Lisinopril | 551 | 145 |
| Amlodipine Besylate | Amlodipine Besylate | 399 | 113 |
| Omeprazole | Omeprazole | 387 | 101 |
| Levothyroxine Sodium | Levothyroxine Sodium | 321 | 88 |
| Metformin Hcl | Metformin Hcl | 275 | 81 |
| Furosemide | Furosemide | 263 | 72 |
| Losartan Potassium | Losartan Potassium | 250 | 74 |
| Metoprolol Tartrate | Metoprolol Tartrate | 246 | 57 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 234 | 56 |
| Hydrochlorothiazide | Hydrochlorothiazide | 198 | 55 |
| Pravastatin Sodium | Pravastatin Sodium | 195 | 59 |
| Gabapentin | Gabapentin | 171 | 50 |
| Metoprolol Succinate | Metoprolol Succinate | 167 | 47 |
| Tamsulosin Hcl | Tamsulosin Hcl | 165 | 43 |
| Metformin Hcl Er | Metformin Hcl | 153 | 45 |
| Eliquis | Apixaban | 147 | 33 |
| Spironolactone | Spironolactone | 138 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 129 | 22 |
| Pantoprazole Sodium | Pantoprazole Sodium | 127 | 36 |
| Simvastatin | Simvastatin | 110 | 30 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 104 | 33 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 104 | 35 |
| Montelukast Sodium | Montelukast Sodium | 100 | 23 |
| Sertraline Hcl | Sertraline Hcl | 99 | 26 |
| Meloxicam | Meloxicam | 96 | 24 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 91 | 18 |
| Ezetimibe | Ezetimibe | 89 | 27 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 89 | 31 |
| Trazodone Hcl | Trazodone Hcl | 88 | 25 |
| Glimepiride | Glimepiride | 85 | 17 |
| Jardiance | Empagliflozin | 85 | 24 |
| Glipizide Er | Glipizide | 83 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 79 | 25 |
| Allopurinol | Allopurinol | 75 | 22 |
| Tramadol Hcl | Tramadol Hcl | 75 | 22 |
| Atenolol | Atenolol | 74 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 73 | 23 |
| Tizanidine Hcl | Tizanidine Hcl | 73 | 27 |
| Trulicity | Dulaglutide | 72 | 15 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 71 | 17 |
| Glipizide | Glipizide | 70 | 20 |
| Potassium Chloride | Potassium Chloride | 65 | 20 |
| Bupropion Xl | Bupropion Hcl | 63 | 14 |
| Carvedilol | Carvedilol | 63 | 16 |
| Famotidine | Famotidine | 62 | 13 |
| Ibuprofen | Ibuprofen | 62 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 61 | 19 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 57 | 14 |
| Pregabalin | Pregabalin | 57 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 56 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 56 | 15 |
| Amitriptyline Hcl | Amitriptyline Hcl | 53 | 16 |
| Prednisone | Prednisone | 53 | 43 |
| Zolpidem Tartrate | Zolpidem Tartrate | 53 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 52 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 51 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | 14 |
| Levetiracetam | Levetiracetam | 46 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 43 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 43 | 23 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 42 | 12 |
| Farxiga | Dapagliflozin Propanediol | 40 | 14 |
| Propranolol Hcl | Propranolol Hcl | 38 | suppressed |
| Azithromycin | Azithromycin | 35 | 30 |
| Chlorthalidone | Chlorthalidone | 35 | 12 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 34 | 23 |
| Januvia | Sitagliptin Phosphate | 33 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 32 | suppressed |
| Lovastatin | Lovastatin | 32 | suppressed |
| Alprazolam | Alprazolam | 31 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 31 | 16 |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 30 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 30 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 29 | suppressed |
| Finasteride | Finasteride | 29 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 27 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 27 | suppressed |
| Ondansetron Odt | Ondansetron | 27 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 26 | suppressed |
| Mirtazapine | Mirtazapine | 26 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 25 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 25 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 24 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 19 |
| Oxycodone Hcl | Oxycodone Hcl | 24 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 24 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 23 | 19 |
| Topiramate | Topiramate | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 22 | suppressed |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 22 | suppressed |
| Bumetanide | Bumetanide | 21 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 20 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 19 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 18 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 17 | suppressed |
| Baclofen | Baclofen | 17 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Invokana | Canagliflozin | 17 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Ozempic | Semaglutide | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 13 | suppressed |
| Flurbiprofen | Flurbiprofen | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | 11 |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Cephalexin | Cephalexin | 11 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.87 · 2 records | Alkermes, Inc. | AREXVY, SHINGRIX, VIVITROL | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error